MergerApr 23, 2026, 04:13 PM
Amicus-BioMarin Merger Gets French FDI Clearance; Closes April 27
AI Summary
Amicus Therapeutics announced that the Ministry of Economics and Finance in France granted clearance for its merger with BioMarin Pharmaceutical Inc. This French FDI clearance satisfies the final condition for the merger, excluding those to be met at closing. The merger, initially agreed upon on December 19, 2025, is now expected to close on April 27, 2026.
Key Highlights
- French FDI clearance granted for Amicus-BioMarin merger.
- Clearance satisfies final pre-closing condition for the merger.
- Merger expected to close on April 27, 2026.
- Merger Agreement was initially signed on December 19, 2025.